Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization. - Wikidata - wikimedia - TriplyDB

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.

http://www.wikidata.org/entity/Q37125302

about

Tsetse salivary gland hypertrophy virus: hope or hindrance for tsetse control?The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein DNA vaccines for biodefense.Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation.Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies

P2860

Q34017981-0512AA78-D4EC-4181-A71E-50E8EAA70F27 Q34039477-87F2A46B-F4D4-44DD-BFFD-629C05D7E36F Q34614260-3114CD08-3856-431D-A1C2-C13D28620481 Q34910424-F7926844-868C-4953-BC9D-C0D55A24D2E1 Q35226200-69A89B72-B386-4173-956B-FACF4CD13785 Q36580893-9F49291B-2C1D-4DD3-8908-4EF9791A619F Q37461110-7A530BD4-7DC1-43E9-89A0-A1DB2F4A790E Q40684847-E2FEE1D0-4966-4B47-8FF2-ACA9F89771EA

P2860

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.

http://www.wikidata.org/entity/Q37125302

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Engineering the vaccinia virus ...... sponse after DNA immunization.

@en

Engineering the vaccinia virus ...... sponse after DNA immunization.

@nl

type

label

Engineering the vaccinia virus ...... sponse after DNA immunization.

@en

Engineering the vaccinia virus ...... sponse after DNA immunization.

@nl

prefLabel

Engineering the vaccinia virus ...... sponse after DNA immunization.

@en

Engineering the vaccinia virus ...... sponse after DNA immunization.

@nl

P1433

Q37125302-D278CE9E-1B27-49B6-8D05-D76C5F5EE119

P1476

Q37125302-7B4918D9-B546-4CA8-BA77-9FD7F6D35E39

P2093

Q37125302-00BDEDAA-6850-4E0B-8F41-9522C4F450D5

Q37125302-3528FE0E-043C-4E95-BC53-FC56436252B0

Q37125302-38E5D742-4D1B-40D6-A4A0-048D7666C71A

P2860

Q37125302-0667DA4F-6528-4706-9607-F27021AFB168

Q37125302-0DD95B6A-4DE7-4BEC-BB9C-880BEF3CAF89

Q37125302-1FDE13D7-6E49-4278-9300-62922016C7E5

Q37125302-219F3477-9084-4F88-AF7F-F47EC6CC980E

Q37125302-279D1E19-44C8-48F9-AE0C-FAC933A9C2B5

Q37125302-3480D93C-2AF0-499C-A25D-347C11CB455F

Q37125302-35D2C9E5-137B-41E1-AC6E-70DD508E3AF1

Q37125302-38151A5B-B8FF-46E2-B626-76F93CEAF92B

Q37125302-3C6A3DC5-10B5-403F-B467-FBBDB8F07525

Q37125302-40B84991-A62A-4BFA-8DAB-835F9EA8DB46

P2888

Q37125302-635C89B0-B4FA-4AFF-9750-592E61565B75

P304

Q37125302-BFCAD33E-9064-4C91-84A9-9A83E9097B6B

P31

Q37125302-7BF9E10F-55F7-47A9-9E1F-737BBDFA8066

P356

Q37125302-317ACD49-AE43-48AB-A943-E212936BEBF0

P478

Q37125302-6A0603FD-CE64-4D19-94D3-41ED4B67D542

P50

Q37125302-55333F7F-1D03-4244-A47A-18BD3DDFCF6B

P577

Q37125302-83D31229-4C7B-43F8-86EF-E0EB4FC19605

P5875

Q37125302-30C99D12-7836-4FA2-951E-7EFA60B92204

P6179

Q37125302-CA96DC21-7A9B-4F1D-B1D2-E3D3FC45E253

P698

Q37125302-464C4583-EEA4-4B0D-B6AA-7D321A362AED

P921

Q37125302-6BAD7A58-8C68-456A-B3DC-A18C75B2D981

Q37125302-91F6F44D-7F6A-4B9F-9222-F3FFF494B31C

P932

Q37125302-96FEB846-2F82-4C23-9D1A-68C6EB9ED84A

P356

P1433

Virology Journal

P1476

Engineering the vaccinia virus ...... sponse after DNA immunization.

@en

P2093

Kaori Shinoda

http://www.w3.org/2001/XMLSchema#string

Kari R Irvine

http://www.w3.org/2001/XMLSchema#string

Linda S Wyatt

http://www.w3.org/2001/XMLSchema#string

P2860

Smallpox as a Biological Weapon

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.

Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction.

Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.

Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain.

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo

Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

P2888

P304

28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1743-422X-6-28

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24174231

http://www.w3.org/2001/XMLSchema#string

P6179

1045532277

http://www.w3.org/2001/XMLSchema#string

P698

19257896

http://www.w3.org/2001/XMLSchema#string

P921

P932

2654435

http://www.w3.org/2001/XMLSchema#string